Э.Уранбайгаль
Loading...
Товч нэр
Э.Уранбайгаль
Бүтэн нэр
Энхбаяр Уранбайгаль
Латин нэр
Enkhbayar Uranbaigali
Албан тушаал
Ахлах багш
Харьяалал
3 results
Now showing 1 - 3 of 3
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Quantitative Serum HBsAg and M2BPGi Levels in Patients with Chronic Hepatitis D(Mongolian National University of Medical Sciences, 2016-11-25); ; ; ;Uyanga BayarsaikhanSumiya DorjObjectives: Quantification of serum HBsAg has several clinical significances such as acting as a biomarker for the hepatitis D virus (HDV)-RNA level and necroinflammatory activity in HDV infection. The WFA+-M2BP is a new glyco-biomarker for liver fibrosis. The aim of this study was to compare the quantitative HBsAg and M2BPGi levels between groups of HBV infected patients with or without HDV infection. Methods: Totally, 112 consecutive HBsAg carriers with or without HDV infection (median age 36 vs 38) were enrolled in the study. Serum HBsAg and M2BPGi levels were measured using commercial tests. Results: Mean qHBsAg concentrations were 3.8 ±0.6 log IU/mL and 3.5 ±0.8 log IU/mL in the HDV positive and HDV negative HBsAg carriers, respectively (p = 0.02). Yet 45 patients out of 56 HDV positive patients have HBsAg level >2000 IU/mL whereas only 33 patients in the HBV mono infected group had concentrations this high. The mean M2BPGi was a 1.2 cut-off index (COI) in the HDV negative group vs. 2.1 COI in the HDV positive group (p<0.001). Conclusion: The qHBsAg level was higher in HDV positive patients compared with HDV negative subjects. But qHBsAg levels were higher in the HBeAg positive subjects despite the presence of HDV infection. The mean M2BPGi value in the HDV positive group was higher than in HDV negative subjects. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Risk Factors for Hepatitis B and C Infection in 10 to 40 Year Olds in Mongolia(Mongolian National University of Medical Sciences, 2019-12-29); ; ; ; Objective: To determine the prevalence of hepatitis B and C infection and its risk factors in Mongolians from 10 to 40 years of age. Method: Randomly selected Mongolians underwent phlebotomy and completed a questionnaire about their medical and family history and risk factors. Participants were screened for qHBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc markers, and Anti-HCV. Results: 6811 people, 2900 (42.7%) males, and 3911 (57.3%) females participated. Most were from Ulaanbaatar (4685, 69%), with the remaining 2126 (31%) from rural areas. Seven percent were HbsAg positive, 4.2% were HCV positive. Of those10-20 years of age, 5.8% (29) had hepatitis B, 6% (17) had hepatitis C. Of those 21 to 40 years of age, 94.2% (469) had hepatitis B, and 94%(268) had hepatitis C. Children whose mother was HBsAg positive were at higher risk of HBsAg positivity (OR 2.152; 95% CI 1.4; 3.2, p < .0001) as well as those with male gender (OR 1.703; 95% CI 1.17;2.46, p < .005), those phlebotomized for lab tests (OR 1.768; 95% CI 1.14; 2.74, p = .011) ,and those immunized against hepatitis B (OR 0.508; 95% CI 0.35; 0.74, p < .0001). HCV infection was associated with history of dental procedures (OR 1.681; 95% CI 1.01; 2.79, p = .045), using glass syringes (OR 2.131; 95% CI 1.54; 2.95, p < .0001), and previously used needles (OR 2.411; 95% CI 1.09;5.29, p = .028). Conclusions: Among the Mongolian population between 10 and 40 years of age, 7.3% were HbsAg positive, 4.2% were Anti-HCV positive. The risk factors were maternal HbsAg positivity, utilization of glass syringes, reusing needles, phlebotomy for laboratory tests, receiving dental treatment, and the absence of hepatitis B immunization. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Results of the National Study of CLEIA Method for the Prevalence of HBV and HCV in the 40-64 Age Population of Mongolia(Mongolian National University of Medical Sciences, 2019-09-25); ; ; ; Objective: Using high-sensitivity test results of CLEIA we aimed to investigate the prevalence of hepatitis B and C virus, and compare levels of AST, ALT, M2BPGI in the Mongolian population in the age between 40-64. Methods: In order to reflect the administrative and geographical features of Mongolia, the sampling was done at three levels: urban, province center, and rural. Immunological test was measured by chemiluminescence enzyme immunoassay (CLEIA). The statistical package for the social sciences (SPSS) version 25 was used for the statistical analyses. Results: The survey covered 3196 people. 71.8 percent of the patients surveyed had a negative in hepatitis test. 10.1 percent had a positive HBsAg test. 17 percent had a positive anti-HCV test. 1.1 percent had both a positive both HBsAg and anti-HCV (<.0001). AST and ALT increased more frequently during co-infection. M2BPGI protein average level in the non-infected group was 1.00 C.O.I, in the HBsAg positive group 1.65 C.O.I, in the anti-HCV positive group 1.83 C.O.I, and in the co-infection group 1.87 C.O.I (<.0001). Conclusion:10.1 percent of 40-64year-olds in Mongolia were infected with hepatitis B virus, and 17 percent had Hepatitis C virus and 1.1 percent had hepatitis B and C virus co-infections. Serum M2BPGi is increasing in hepatitis C virus infection and in co-infection.
